RT Journal Article
SR Electronic
T1 A latent outcome variable approach for Mendelian randomization using the expectation maximization algorithm
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.24.24312485
DO 10.1101/2024.08.24.24312485
A1 Amente, Lamessa Dube
A1 Mills, Natalie T
A1 Le, Thuc Duy
A1 Hyppönen, Elina
A1 Lee, S Hong
YR 2024
UL http://medrxiv.org/content/early/2024/08/26/2024.08.24.24312485.abstract
AB Mendelian randomization (MR) is a widely used tool to uncover causal relationships between exposures and outcomes. However, existing MR methods can suffer from inflated type I error rates and biased causal effects in the presence of invalid instruments. Our proposed method enhances MR analysis by augmenting latent phenotypes of the outcome, explicitly disentangling horizontal and vertical pleiotropy effects. This allows for explicit assessment of the exclusion restriction assumption and iteratively refines causal estimates through the expectation-maximization algorithm. This approach offers a unique and potentially more precise framework compared to existing MR methods. We rigorously evaluate our method against established MR approaches across diverse simulation scenarios, including balanced and directional pleiotropy, as well as violations of the Instrument Strength Independent of Direct Effect (InSIDE) assumption. Our findings consistently demonstrate superior performance of our method in terms of controlling type I error rates, bias, and robustness to genetic confounding. Additionally, our method facilitates testing for directional horizontal pleiotropy and outperforms MR-Egger in this regard, while also effectively testing for violations of the InSIDE assumption. We apply our method to real data, demonstrating its effectiveness compared to traditional MR methods. This analysis reveals the causal effects of body mass index (BMI) on metabolic syndrome (MetS) and a composite MetS score calculated by the weighted sum of its component factors. While the causal relationship is consistent across most methods, our proposed method shows fewer violations of the exclusion restriction assumption, especially for MetS scores where horizontal pleiotropy persists and other methods suffer from inflation.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://github.com/lamessad/MRLOVA Funding StatementLamessa Amente acknowledges funding from the Australian Government Research Training Program (RTP) scholarship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The GWAS summary statistics were publicly available prior to the initiation of this study. The accessible links are as follows: BMI https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files#GWAS_Anthropometric_2015_BMI_Summary_Statistics/SNP_gwas_mc_merge_nogc.tbl.uniq.gz MetS score https://vu.data.surfsara.nl/index.php/s/2CXgBg4oE0dAYmo MetS https://www.ebi.ac.uk/gwas/publications/31589552 Lipids(LDL, HDL, and TG) http://csg.sph.umich.edu/willer/public/lipids2013/ systolic Blood pressure https://broad-ukb-sumstats-us-east-1.s3.amazonaws.com/round2/additive-tsvs/4080_raw.gwas.imputed_v3.both_sexes.tsv.bgz diastolic Blood pressure https://broad-ukb-sumstats-us-east-1.s3.amazonaws.com/round2/additive-tsvs/4079_raw.gwas.imputed_v3.both_sexes.tsv.bgz CAD http://www.cardiogramplusc4d.org/media/cardiogramplusc4d-consortium/data-downloads/cad.additive.Oct2015.pub.zipI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. https://github.com/lamessad/MRLOVA